SCHEMBL8328859

SCHEMBL8328859

CN(C)CCN(C(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1)C(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.40
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.35
MDM2 Q00987 1/20 0.35
DRD4 P21917 1/20 0.35
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
SIGMAR1 Q99720 2/20 0.33
SLC6A9 P48067 1/20 0.33
S1PR1 P21453 1/20 0.33
CACNA2D1 P54289 1/20 0.31
CACNA1B Q00975 1/20 0.31
CACNB1 Q02641 1/20 0.31
CACNA1C Q13936 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7127624 0.79 SIGMAR1 (0.45) HSD17B10ALDH1A1KDM4EMDM2DRD4
SCHEMBL14569709 0.79 HSD17B10 (0.44) HSD17B10ALDH1A1SLC6A9S1PR1
SCHEMBL20457594 0.79 ALDH1A1 (0.58) HSD17B10ALDH1A1KDM4EMDM2DRD4
SCHEMBL22954477 0.77 SIGMAR1 (0.41) HSD17B10ALDH1A1KDM4EMDM2DRD4
SCHEMBL31679390 0.77 HSD17B10 (0.45) HSD17B10ALDH1A1KDM4EMDM2DRD4
SCHEMBL31679340 0.77 HSD17B10 (0.45) HSD17B10ALDH1A1KDM4EMDM2DRD4
SCHEMBL20187636 0.74 HSD17B10 (0.42) HSD17B10ALDH1A1KDM4EMDM2DRD4
SCHEMBL22954478 0.74 SIGMAR1 (0.41) HSD17B10ALDH1A1KDM4EMDM2DRD4
Tetraxetan SCHEMBL5370171 0.73 HSD17B10 (0.58) HSD17B10ALDH1A1KDM4EMEN1KMT2A
SCHEMBL6848102 0.73 HSD17B10 (0.64) HSD17B10ALDH1A1KDM4ESLC6A9S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972307-A ADMINISTERING TO HUMAN OR ANIMAL BODY AN EFFECTIVE AMOUNT OF A DIAGNOSTIC AGENT COMPRISES A METAL CHELATE OF A COMPOUND HAVING TWO MACROCYCLIC CHELANT GROUPS LINKED BY A BRIDGE CONTAINING ESTER OR AMIDE BOND NYCOMED SALUTAR, INC. (US) 1999-10-26 US disclosed
US-5650133-A CHELATING AGENTS USEFUL IN DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS NYCOMED SALUTAR (US) 1997-07-22 US disclosed
EP-0722442-A1 POLYAZACYCLOALKANES AS DICHELANTS NYCOMED SALUTAR, INC. (US) 1996-07-24 EP disclosed
WO-1995009848-A2 POLYAZACYCLOALKANES AS DICHELANTS NYCOMED SALUTAR, INC. (US) 1995-04-13 WO disclosed